Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
120.00
304.00
-184.00
-60.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
120.00
304.00
-184.00
-60.53%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
10.00
-7.00
-70.00%
Raw Materials Consumed
71.00
179.00
-108.00
-60.34%
Power & Fuel Cost
2.00
4.00
-2.00
-50.00%
Employee Cost
4.00
21.00
-17.00
-80.95%
Operating Expenses
2.00
13.00
-11.00
-84.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
25.00
-24.00
-96.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
7.00
-6.00
-85.71%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
270.00
-182.00
-67.41%
Operating Profit (PBDIT) excl Other Income
32.00
33.00
-1.00
-3.03%
Other Income
0.00
14.00
-14.00
-100.00%
Operating Profit (PBDIT)
32.00
48.00
-16.00
-33.33%
Interest
3.00
4.00
-1.00
-25.00%
Profit before Depriciation and Tax
28.00
43.00
-15.00
-34.88%
Depreciation
1.00
7.00
-6.00
-85.71%
Profit Before Taxation & Exceptional Items
26.00
36.00
-10.00
-27.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26.00
36.00
-10.00
-27.78%
Provision for Tax
6.00
9.00
-3.00
-33.33%
Profit After Tax
20.00
26.00
-6.00
-23.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
205.00
-203.00
-99.02%
Profit Available for appropriations
22.00
231.00
-209.00
-90.48%
Appropriations
22.00
231.00
-209.00
-90.48%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
6.37
40.36
-33.99
-84.22%
Profit And Loss - Net Sales
Net Sales 120.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024
Profit And Loss - Interest
Interest 3.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 20.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024






